Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 51Neoplasms 29Prostatic Neoplasms 28Head and Neck Neoplasms 15Lung Neoplasms 14Ovarian Neoplasms 9Pancreatic Neoplasms 8Urinary Bladder Neoplasms 6Sarcoma 6Oropharyngeal Neoplasms 6Hematologic Neoplasms 6Gastrointestinal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Depression 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Motor Activity 4Melanoma 4Lymphoma 4Anxiety Disorders 4Stomach Neoplasms 3Pain 3Osteosarcoma 3

Interventions

Cyclophosphamide 47Rituximab 31fludarabine 29Specimen Handling 13Magnetic Resonance Spectroscopy 13Doxorubicin 13pirtobrutinib 11Vincristine 11Prednisone 11fludarabine phosphate 10Immunotherapy, Adoptive 10Etoposide 10Bendamustine Hydrochloride 10obinutuzumab 8Lenalidomide 8Biopsy 8venetoclax 7polatuzumab vedotin 7glofitamab 7zanubrutinib 6pembrolizumab 6Dexamethasone 6tafasitamab 5ibrutinib 5etoposide phosphate 5acalabrutinib 5Leukapheresis 5tazemetostat 4loncastuximab tesirine 4Nivolumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Surveys and Questionnaires × 1 year × Clear all
NCT07588698 2026-05-15

Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma

University of California, San Francisco

Phase 2 Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡